These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 3285834)
1. Single dose comparison of torasemide and furosemide in patients with advanced renal failure. Klütsch K; Grosswendt J; Haecker W Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834 [TBL] [Abstract][Full Text] [Related]
2. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure. Kult J; Häcker W; Glocke M Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837 [TBL] [Abstract][Full Text] [Related]
3. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure. Mourad G; Haecker W; Mion C Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835 [TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacodynamics of torasemide and furosemide in patients with oedema. Herchuelz A; Deger F; Douchamps J; Ducarne H; Broekhuysen J Arzneimittelforschung; 1988 Jan; 38(1A):180-3. PubMed ID: 3285831 [TBL] [Abstract][Full Text] [Related]
5. Torasemide, a new potent diuretic. Double-blind comparison with furosemide. Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530 [TBL] [Abstract][Full Text] [Related]
6. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver. Brunner G; von Bergmann K; Häcker W; von Möllendorff E Arzneimittelforschung; 1988 Jan; 38(1A):176-9. PubMed ID: 3285830 [TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide. Stroobandt R; Dodion L; Kesteloot H Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):151-8. PubMed ID: 6762167 [TBL] [Abstract][Full Text] [Related]
8. High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure. Boesken WH; Kult J Clin Nephrol; 1997 Jul; 48(1):22-8. PubMed ID: 9247774 [TBL] [Abstract][Full Text] [Related]
17. Torasemide, a new loop diuretic, in patients with chronic renal failure. Russo D; Gazzotti RM; Testa A Nephron; 1990; 55(2):141-5. PubMed ID: 2194134 [TBL] [Abstract][Full Text] [Related]
18. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. Laffi G; Marra F; Buzzelli G; Azzena G; Meacci E; De Feo ML; La Villa G; Gentilini P Hepatology; 1991 Jun; 13(6):1101-5. PubMed ID: 2050329 [TBL] [Abstract][Full Text] [Related]
20. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension. Spannbrucker N; Achhammer I; Metz P; Glocke M Arzneimittelforschung; 1988 Jan; 38(1A):190-3. PubMed ID: 3285833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]